BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

840 related articles for article (PubMed ID: 9207802)

  • 1. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
    Im DD; Duska LR; Rosenshein NB
    Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
    Tierney KE; Lin PS; Amezcua C; Matsuo K; Ye W; Felix JC; Roman LD
    Am J Obstet Gynecol; 2014 Apr; 210(4):366.e1-366.e5. PubMed ID: 24370689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH; Yew WS; Ho TH
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
    Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
    Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.
    Wolf JK; Levenback C; Malpica A; Morris M; Burke T; Mitchell MF
    Obstet Gynecol; 1996 Jul; 88(1):82-6. PubMed ID: 8684768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial and endocervical curettage findings at the time of cervical conization.
    Presley JJ; Hernandez E; Mudafort E; Miyazawa K
    J Reprod Med; 1987 Feb; 32(2):99-102. PubMed ID: 3560085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.